Metformin had anticancer effects including mTOR pathway blockade leading to downregulation of neovascularization [12], tumor cell apoptosis induction at the mitochondrial level [13], and inhibition of epithelial-to-mesenchymal transition [14]. Here, MTOR is linked to neoplasm.